Pharma Stocks
-
Cipla and 4 Other Pharma Stocks Leading the Generic Medicine Segment to Watch Out For
Synopsis: Generic medicines are cost-effective versions of patented drugs that meet identical safety and efficacy standards. India leads the global…
Read More » -
Stock Market News for Feb 21, 2026
3 news published. Stay ahead of the market with our list of today’s most important stock news and financial updates.…
Read More » -
Under?the?Radar Pharma Giant US Investors Keep Missing
Otsuka just moved on new drug catalysts and pipeline updates—but most U.S. portfolios still ignore this $10bn+ Japan pharma name.…
Read More » -
Dr. Reddy’s Stock Pops on US Launch Momentum: Buy the Breakout?
Dr. Reddy’s is quietly tightening its grip on the US generics market while the stock re-rates higher. Here’s what the…
Read More » -
Deutsche Bank Upgrades Merck (MRK) to Buy, Sees “Clear Path” Beyond Keytruda Patent Cliff
Merck & Co., Inc. (NYSE:MRK) is included among the 16 Best Dividend Stocks with Rising Payouts. On February 13, Deutsche…
Read More » -
Merck vs. Bristol Myers: Which Pharma Stock Is a Better Pick in 2026? – February 20, 2026
Key Takeaways Bristol Myers emerges as the stronger near-term pick over Merck. BMY’s new drugs, label expansions and $2B cost-savings…
Read More » -
Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2016
Stock Performance and Market Context On 20 Feb 2026, Mankind Pharma Ltd’s stock price fell to Rs.2016, the lowest level…
Read More » -
Is Pfizer Stock the Only Big Pharma Name I’d Buy and Hold Through Any Market Crash?
Key Points Pfizer has reached a transition point following declines of some of its biggest blockbusters. The pharma giant is…
Read More » -
Is Pfizer Stock the Only Big Pharma Name I’d Buy and Hold Through Any Market Crash?
New products are already generating growth. Pfizer (PFE 0.73%) is the name behind one of the world’s top-selling products: the…
Read More » -
Lupin, Biocon, Torrent Pharma Show Technical Strength
The Technical Breakout Candidates The Indian pharmaceutical sector has demonstrated significant strength, outpacing the broader Nifty 50 index with a…
Read More »